Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Immunogenicity of Two Live, Attenuated Oral Shigella Sonnei Vaccines WRSs2 and WRSs3
This study is currently recruiting participants.
Verified February 2013 by National Institute of Allergy and Infectious Diseases (NIAID)
Study NCT01336699   Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

First Received on April 14, 2011.   Last Updated on May 16, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Shigellosis
Additional conditions recognized in this trial
Dysentery, Bacillary
More general conditions related to this trial
Bacterial Infections
Digestive System Diseases
Dysentery
Enterobacteriaceae Infections
Gastroenteritis
Gastrointestinal Diseases
Gram-Negative Bacterial Infections
Intestinal Diseases
Interventions listed in this trial
Placebo
WRSs3
WRSs2
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services